PV Bulletin

ANSM Training on Pharmacovigilance Signal Detection Methodologies

The ANSM conducted a restricted session focusing on signal detection processes within pharmacovigilance.

Primary source: Dailymotion Video Player

PV Impact Brief

Urgency: HighConfidence: high

What changed

The structured methodology for evaluating and classifying risks has been formally implemented, with classification into four risk levels: SHR, SRI, SRM, and SRF.

Why it matters

This change ensures pharmacovigilance activities are aligned with rigorous national standards, enhancing the assessment of safety signals and improving public health outcomes.

Action needed

Pharmacovigilance teams must adopt a structured classification approach to risk analysis, impacting how cases are assessed and notified.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Policy change details

Document type
Notice / Meeting
Policy status
new
Publication date
2026-06-29
Policy change
The ANSM held a restricted session of its Permanent Scientific Committee on Pharmacovigilance focusing on signal detection methodology and training.

Key changes

Session dedicated to the review of signal detection processes and pharmacovigilance surveillance methodologies within the agency's committee framework.

Affected workflows

Signal Management

Responsible groups

Signal Management TeamSafety Committees

PV impact

Ensures ongoing alignment with national surveillance standards and training for signal evaluation. Reflects the agency's focus on methodological rigor in safety signal assessment.

View regulator source

Source document details

Exact policy details

Date of Committee Meeting
19/09/2023
Applies to: Date of the session related to pharmacovigilance and signal management.
Ordre du jour (18/09/2023) · p. 1 · High · Source
Functionality of Signal Working Group
The working group includes 14 representatives and aims to provide an opinion on drug risks.
Applies to: Describes the structure and purpose of the Signal subgroup.
Compte rendu (18/10/2023), page 6 · p. 6 · High · Source
Risk Analysis Classification
Cases are classified into four risk levels: SHR, SRI, SRM, and SRF.
Applies to: Describes how risks are categorized during evaluations.
Compte rendu (18/10/2023), page 6 · p. 6 · High · Source

Workflow rule impacts

Signal ManagementSignal Management Unit

Changes in how pharmacovigilance teams assess and notify risks based on structured classifications.

Implementation of a structured approach for evaluating and classifying risks.

Discussion on the handling of marked cases and medication errors. · p. 7 · High · Source

Extracted documents

Evidence and confidence

Confidence: highSource updated: Jun 29, 2026

Full briefing

Practical implication

Pharmacovigilance teams must adopt a structured classification approach to risk analysis, impacting how cases are assessed and notified.

On September 19, 2023, the French National Agency for the Safety of Medicines and Health Products (ANSM) held a session to review signal detection methodologies and training, emphasizing alignment with national surveillance standards. This reflects the agency's commitment to methodological rigor in safety assessments.

What changed: The structured methodology for evaluating and classifying risks has been formally implemented, with classification into four risk levels: SHR, SRI, SRM, and SRF.

Why it matters: This change ensures pharmacovigilance activities are aligned with rigorous national standards, enhancing the assessment of safety signals and improving public health outcomes.

Practical implication: Pharmacovigilance teams must adopt a structured classification approach to risk analysis, impacting how cases are assessed and notified.

View original source

Published from the Firecrawl policy change extraction pipeline.

#Safety Signals#new#Country Requirement#policy-change#firecrawl-policy-agent#Notice / Meeting#French National Agency for the Safety of Medicines and Health Products (ANSM)

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward